Documents & Downloads

Pocuvotide satetraxetan

Anticancer Agent

Pocuvotide satetraxetan is an anticancer agent that targets tumor cells through selective binding. When labeled with the radionuclide 177Lu, it enables precise imaging for diagnostic purposes in cancer research. This compound is valuable for studying tumor development and evaluating treatment efficacy in preclinical models.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	1970173-58-0
Applications	Anticancer Agent
Formula	C₃₆H₅₄N₈O₁₅S
Molecular Weight	870.92
SMILES	C(C1N(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)C1)C2=CC=C(NC(NCCCC[C@H](NC(N[C@@H](CCC(O)=O)C(O)=O)=O)C(O)=O)=S)C=C2

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.